Isolated splenic high-grade serous carcinoma: A case report

Isolated splenic high-grade serous carcinoma: A case report

We present a unique case of high-grade serous carcinoma isolated to the spleen at the time of diagnosis, without any tumor present in the ovary, fallopian tubes, omentum or uterus, which was pathologically consistent with metastatic Mullerian carcinoma. Tumor sequencing with the MSK-IMPACT (Memorial...

Full description

Bibliographic Details
Main Authors:	Ralph Rogers, Sarah Ehmann, William P. Tew, Vance Broach
Format:	Article
Language:	English
Published:	Elsevier 2021-08-01
Series:	Gynecologic Oncology Reports
Subjects:	High-grade serous carcinoma Splenic Mullerian carcinoma Pluripotent spleen cell TP53 hotspot mutation PALB2 mutation ARID1 somatic mutation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352578921001223

Similar Items

KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions
by: Kohei Nakamura, et al.
Published: (2016-04-01)

Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary
by: Yan Xu, et al.
Published: (2017-12-01)

Improved survival of patients with hypermutation in uterine serous carcinoma
by: Alessandro D. Santin, et al.
Published: (2015-04-01)

Concurrent isolated retroperitoneal HGSC and STIC defined by somatic mutation analysis: a case report
by: Kazuaki Suda, et al.
Published: (2019-02-01)

Serous Carcinoma of the Endometrium with Mesonephric-Like Differentiation Initially Misdiagnosed as Uterine Mesonephric-Like Adenocarcinoma: A Case Report with Emphasis on the Immunostaining and the Identification of Splice Site <i>TP53</i> Mutation
by: Sangjoon Choi, et al.
Published: (2021-04-01)

The mutational landscape of hepatocellular carcinoma
by: Ju-Seog Lee
Published: (2015-09-01)

Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers
by: Zhe-Yu Hu, et al.
Published: (2020-08-01)

TP53 and PTEN as driver mutations in Zenker's carcinoma—a clinical presentation
by: Zsanett Noel, et al.
Published: (2020-12-01)

High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the “SET” feature of high-grade serous carcinoma to the “STEM” feature
by: Yuichiro Hatano, et al.
Published: (2019-01-01)

Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient
by: Ryan Kahn, et al.
Published: (2016-08-01)

Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: A cross‐sectional study (2016‐2017)
by: Christian S. Alvarez, et al.
Published: (2020-06-01)

Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma
by: Venkatesh Kancherla, et al.
Published: (2018-02-01)

Comprehensive genomic profiling of high‐grade serous ovarian carcinoma from Chinese patients identifies co‐occurring mutations in the Ras/Raf pathway with TP53
by: Fangfang Zhong, et al.
Published: (2019-07-01)

The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
by: Go Omura, et al.
Published: (2017-12-01)

Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report
by: Kayo Inoue, et al.
Published: (2020-05-01)

Mutated p53 in HGSC—From a Common Mutation to a Target for Therapy
by: Aya Saleh, et al.
Published: (2021-07-01)

Genotyping of Human Papillomavirus and TP53 Mutaions at Exons 5 to 7 in Lung Cancer Patients from Iran
by: Hossein Jafari, et al.
Published: (2013-06-01)

Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis
by: T. Rinda Soong, et al.
Published: (2018-11-01)

High-grade versus low-grade serous carcinoma of the ovary – current differential diagnosis and perspectives
by: Manuela POPA, et al.
Published: (2018-12-01)

Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progression
by: Soulafa Mamlouk, et al.
Published: (2020-09-01)

IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesis
by: Wang, Yiying, et al.
Published: (2014)

Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next‐generation sequencing technique
by: Saki Manabe, et al.
Published: (2020-08-01)

The <it>R337H </it>mutation in <it>TP53 </it>and breast cancer in Brazil
by: Gomes Magda CB, et al.
Published: (2012-03-01)

Interaction between the microbiome and TP53 in human lung cancer
by: K. Leigh Greathouse, et al.
Published: (2018-08-01)

Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer
by: Dong, Y., et al.
Published: (2022)

Spectrum of TP53 Mutations in BRCA1/2 Associated High-Grade Serous Ovarian Cancer
by: Ulyana A. Boyarskikh, et al.
Published: (2020-07-01)

Pathogenic Heteroplasmic Somatic Mitochondrial DNA Mutation Confers Platinum-Resistance and Recurrence of High-Grade Serous Ovarian Cancer
by: Ni J, et al.
Published: (2020-11-01)

TP53 Mutation Related and Directly Regulated lncRNA Prognosis Markers in Hepatocellular Carcinoma
by: Zhang X, et al.
Published: (2021-08-01)

Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies
by: Karolina Stachyra, et al.
Published: (2021-06-01)

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
by: Se Ik Kim, et al.
Published: (2019-05-01)

Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature
by: Rosanna Asselta, et al.
Published: (2021-05-01)

Importance of serous intraepithelial ovarian tubal carcinomas in the occurrence of "high-grade" serous carcinomas and / or peritoneal serous carcinomas of unknown primary origin.
by: I. S. Shponka, et al.
Published: (2020-04-01)

Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnostics
by: O. G. Grigoruk, et al.
Published: (2016-09-01)

The poor prognosis of sarcomatoid carcinoma arising from low grade serous ovarian cancer: A case report and review of the literature
by: Paulina Haight, et al.
Published: (2021-05-01)

Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
by: Mitchell Acland, et al.
Published: (2020-12-01)

Genetic Alterations and Transcriptional Expression of m6A RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma
by: Gui-Qi Zhu, et al.
Published: (2020-07-01)

A Remarkable and Durable Response to Sintilimab and Anlotinib in the First-Line Treatment of an Anaplastic Thyroid Carcinoma without Targetable Genomic Alterations: A Case Report
by: Gui L, et al.
Published: (2021-04-01)

p53-protein over-expression and gene mutational of oral carcinoma in-situ
by: Mei Syafriadi, et al.
Published: (2007-06-01)

CT features of low grade serous carcinoma of the ovary
by: Harpreet K. Pannu
Published: (2015-01-01)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
by: Renan Ribeiro e Ribeiro, et al.
Published: (2021-05-01)